Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,6811,700 of 20,252 grants

Active NON-SBIR/STTR RPGS
Interrogation of the oxidative-stress-induced leukemia program in vivo usingmetabolic imaging
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT (unchanged from initial application) Acute myeloid leukemia (AML) is a genetically complex and heterogeneous set of diseases characterized by a diverse set...

$355.5K
USD
Completed NON-SBIR/STTR RPGS
PA-23-189 for Kaya Johnson to CA260126-01: Identifying a proteomic signature for breast cancer detection in breast milk and serum
NATIONAL CANCER INSTITUTE Clarkson University United States 2024 – 2025

Program Director/Principal Investigator (Last, First, Middle): Darie, Costel C. Supplement Application (PAR-18-714) for Candidate Kaya Johnson Funded parent grant CA260126-01: Iden...

$213.6K
USD
Completed NON-SBIR/STTR RPGS
Empowering Latinas to Obtain Guideline-Concordant Breast Cancer Screenings
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2024 – 2025

ABSTRACT Proposed Research Plan. Latinas are less likely to receive timely diagnostic care and are more likely to experience greater psychosocial distress following screening mammo...

$285.8K
USD
Completed RESEARCH CENTERS
Clinical Protocol and Data Management
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2025

CLINICAL PROTOCOL AND DATA MANAGEMENT PROJECT SUMMARY The Mayo Clinic Cancer Center (MCCC) Clinical Protocol and Data Management (CPDM) functions are administratively overseen by t...

Active NON-SBIR/STTR RPGS
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2027

Abstract Cancer immunotherapies have achieved unprecedented clinical responses and are revolutionizing cancer treatments. Despite of the tremendous success of cancer immunotherapie...

$294.1K
USD
Completed NON-SBIR/STTR RPGS
Selective Radionuclide Delivery for Precise Bone Marrow Niche Alterations - Admin Supplement
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2025

PROJECT SUMMARY / ABSTRACT (From Parent Grant Application) The bone marrow niche houses hematopoietic stem cells (HSCs), cells that self-renew and differentiate into vital blood co...

$433K
USD
Active NON-SBIR/STTR RPGS
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2026

PROJECT SUMMARY Gene expression, the flow of genetic information from DNA to messenger RNA (mRNA) to protein, involves delicate regulation by a group of small RNAs named microRNAs....

$264.7K
USD
Completed NON-SBIR/STTR RPGS
Refining and expanding breast dosimetry for the Sacramento Area Breast Imaging Registry
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2025

Abstract The SABIR (Sacramento Area Breast Imaging Registry) was created to provide insights regarding the best approaches for breast cancer screening, surveillance, and to compare...

$1.18M
USD
Completed NON-SBIR/STTR RPGS
Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2025

Refer to Parent Grant SUMMARY AND SPECIFIC AIMS OF PARENT GRANT (R21CA282629, PI: KATZ). Although T cell mediated immune responses are critical for successful immunotherapy, T cell...

$330.5K
USD
Completed NON-SBIR/STTR RPGS
Identification of metabolic adducts associated with prostate cancer progression in African American men Supplement
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2025

Abstract Prostate cancer (PCa) is the second highest cause of cancer-related deaths in men. African American/Black (AA/B) men are disproportionally impacted by PCa with a 60% highe...

$1.12M
USD
Active NON-SBIR/STTR RPGS
Supplement to Promote Diversity: Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2026

No Changes to the Abstract Chemotherapy-related cognitive impairment (CRCI, chemobrain), chemotherapy-induced peripheral neuropathy (CIPN) and gait changes are debilitating side-ef...

$331.4K
USD
Active NON-SBIR/STTR RPGS
Diversity Supplements for Imaging Research in Prostate Cancer Health Disparities
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2026

PROJECT SUMMARY African American (AA) men face the highest incidence and mortality rates from prostate cancer (PCa) in the United States. Prostate multi-parametric MRI (mpMRI) is a...

$425.7K
USD
Active NON-SBIR/STTR RPGS
Improvement of cellular immunotherapy during dysbiosis - A. A. Brint Supplement
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2024 – 2026

Project Summary The use of antibiotics has significantly increased in recent years. Antibiotics (ABX) severely alter the gut microbiome, destroying potentially pathogenic bacteria,...

$432.8K
USD
Active NON-SBIR/STTR RPGS
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2026

Abstract The overarching goal of this study is to identify effective metabolic based diagnostic and therapeutic strategies to improve the overall survival of patients with Non-smal...

$339.9K
USD
Completed RESEARCH CENTERS
Tumor-associated macrophage reprogramming through PARP14 inhibition in muscle-invasive bladder cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2024

Project summary This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-21-100. This NCI Early-stage Surgeon Scientist Program...

$1.48M
USD
Completed NON-SBIR/STTR RPGS
The second phase of NIH Common Fund 4D Nucleome Network Organizational Hub
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2024 – 2024

The second phase of NIH Common Fund 4D Nucleome Network Organizational Hub Abstract The second phase of the 4DN program requires an efficient organizational center to synergize the...

$2.33M
USD
Completed OTHER RESEARCH-RELATED
Targeting Kinase Inhibitor Induced Signaling Plasticity in Patients with Ph-Like ALL
NATIONAL CANCER INSTITUTE Loma Linda University United States 2024 – 2026

Project Summary Major scientific and therapeutic advances have improved outcomes of patients with B-cell acute lymphoblastic leukemia (B-ALL) over the last four decades. Addition o...

$1.93M
USD
Completed RESEARCH CENTERS
Mayo Comprehensive Cancer Center Grant (Funded Extension Supplement)
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2025

OVERALL PROJECT SUMMARY The Mayo Clinic Comprehensive Cancer Center (MCCCC) has engaged in intensive strategic planning and evaluation efforts, formed a new External Scientific Adv...

$57.3M
USD
Completed NON SBIR/STTR CONTRACTS
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT
NATIONAL CANCER INSTITUTE Fisher Bioservices, Inc United States 2024 – 2025

The purpose of this contract is to operate and maintain the National Cancer Institute's Chemotherapeutic Agents Repository (NCI-CAR). The principal goals of this contract are...

$17.18M
USD
Completed RESEARCH CENTERS
P30 Administrative Supplement for Assessing and Enhancing Survivorship Care
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2025

PROJECT ABSTRACT The complexity of childhood cancer survivorship care delivery necessitates systematic optimization, especially as the U.S. survivor population approaches 580,000....

$1,000K
USD